Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Regeneron

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.

regeneron

Detailed results for Regeneron's antibody cocktail continue to show benefit in high-risk COVID-19 outpatients

Detailed results for Regeneron's antibody cocktail continue to show benefit in high-risk COVID-19 outpatients

Regeneron’s antibody cocktail REGEN-COV cuts the risk of hospitalisation or death by 70% in non-hospitalised COVID-19 patients, according to detailed phase 3 trial results. ... Regeneron is collaborating with Swiss pharma company Roche to bolster the

Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments

Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments In addition to Bourla, Regeneron’s CEO Leonard Schleifer also said he expects an “ongoing global need” for COVID-19 therapeutics, such as the company’s monoclonal antibody treatment REGEN-COV. ... In Q1, Regeneron recorded US net sales of $262m

UK-based challenge study to re-expose healthy adults to COVID-19

UK-based challenge study to re-expose healthy adults to COVID-19 If any participants develop symptoms, they will be given Regeneron’s monoclonal antibody treatment REGEN-COV, and will only be discharged when they are no longer infected with the virus and

Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk

Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk Roche and Regeneron’s COVID-19 antibody cocktail REGEN-COV reduced the risk of symptomatic infections by 81% in a phase 3 prevention trial. ... So far (as of April 2021) over 25, 000 people have participated in clinical trials involving REGEN-COV,

Pfizer launches early study of COVID-19 antiviral therapeutic

Pfizer launches early study of COVID-19 antiviral therapeutic With its antiviral candidates, Pfizer is now aiming to enter the COVID-19 therapeutic space, where Regeneron and Eli Lilly have largely dominated so far. ... Regeneron’s antibody cocktail ( casirivimab and imdevimab) has been granted an emergency use

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...